1. World Health Organization. Clinical management of COVID-19: living guideline, 23 June 2022 [Internet]. World Health Organization; 2022.
2. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656-665.
doi:10.1016/j.jinf.2020.03.041 3. Frontera JA, Valdes E, Huang J, et al. Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med. 2020;48(12):e1211-e1217.
doi:10.1097/CCM.0000000000004605 4. Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest. 2020;43(8):1137-1139.
doi:10.1007/s40618-020-01301-w 5. Yousaf Z, Al-Shokri SD, Al-Soub H, Mohamed MFH. COVID-19-associated SIADH: a clue in the times of pandemic! Am J Physiol Endocrinol Metab. 2020;318(6):E882-E885.
doi:10.1152/ajpendo.00178.2020 6. Habib MB, Sardar S, Sajid J. Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19. IDCases. 2020;21:e00859.
doi:10.1016/j.idcr.2020.e00859 7. Khidir RJY, Ibrahim BAY, Adam MHM, et al. Prevalence and outcomes of hyponatremia among COVID-19 patients: a systematic review and meta-analysis. Int J Health Sci (Qassim). 2022;16(5):69-84.
8. Gheorghe G, Ilie M, Bungau S, Stoian AMP, Bacalbasa N, Diaconu CC. Is there a relationship between COVID-19 and hyponatremia?Medicina (Kaunas). 2021;57(1):55.
doi:10.3390/medicina57010055 9. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21): 1581-1589.
doi:10.1056/NEJM200005253422107 10. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.Am J Med. 2013;126(10 Suppl 1):S1-S42.
doi:10.1016/j.amjmed.2013.07.006 11. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064-2072.
doi:10.1056/NEJMcp066837 12. Sheikh MM, Ahmad E, Jeelani HM, Riaz A, Muneeb A. COVID-19 pneumonia: an emerging cause of syndrome of inappropriate antidiuretic hormone. Cureus. 2020;12(6):e8841.
doi:10.7759/cureus.8841 13. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-1028.
doi:10.1515/cclm-2020-0369 14. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-847.
doi:10.1002/ajh.25829 15. Garrahy A, Thompson CJ. Hyponatremia and glucocorticoid deficiency. Front Horm Res. 2019;52: 80-92.
doi:10.1159/000493239 16. Machiraju PK, Alex NM, Safinaaz, Vadamalai V. Hyponatremia in coronavirus disease-19 patients: a retrospective analysis. Can J Kidney Health Dis. 2021;8:20543581211067069.
doi:10.1177/20543581211067069 17. Tzoulis P, Waung JA, Bagkeris E, et al. Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19.J Clin Endocrinol Metab. 2021;106(6):1637-1648.
doi:10.1210/clinem/dgab107 18. Tezcan ME, Dogan Gokce G, Sen N, Zorlutuna Kaymak N, Ozer RS. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients.New Microbes New Infect. 2020;37:100753.
doi:10.1016/j.nmni.2020.100753 19. Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020; 57(3):262-265.
doi:10.1177/0004563220922255 20. Ayat P, Alam S, Capric V, Chen J, McFarlane SI. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) with severe hyponatremia as the initial and sole presentation of COVID-19 infection: a case report and pathophysiologic insights. Cureus. 2023;15(1):e34161.
doi:10.7759/cureus.34161 21. Kurian SJ, Mathews SP, Paul A, et al. Association of serum ferritin with severity and clinical outcome in COVID-19 patients: an observational study in a tertiary healthcare facility. Clin Epidemiol Glob Health. 2023; 21:101295.
doi:10.1016/j.cegh.2023.101295 22. Yazdanpanah P, Vafaei F, Afrouz S. Diagnosis of coronavirus disease 2019 by potential laboratory factors. J Clinic Care Skill. 2022;3(4):149-154.
23. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-1031.
doi:10.1007/s40618-020-01276-8 24. Jensterle M, Herman R, Janez A, et al. The relationship between COVID-19 and hypothalamic-pituitary-adrenal axis: a large spectrum from glucocorticoid insufficiency to excess-the CAPISCO international expert panel. Int J Mol Sci. 2022;23(13):7326.
doi:10.3390/ijms23137326 25. Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology. 2022;30(3):789-798.
doi:10.1007/s10787-022-00992-2 26. Adekanmbi O, Ilesanmi O, Idowu O, et al. Characteristics and outcomes of patients hospitalized with COVID-19 at a tertiary hospital in Nigeria. Afr Health Sci. 2023;23(1):72-82.
doi:10.4314/ahs.v23i1.9